Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas

BACKGROUND: In patients with adenocarcinoma of the pancreas, there are no standard second-line regimens. Many pre-clinical studies have shown that metformin alone or when combined with paclitaxel has antitumour effects on this tumour. We have tested here the combination of paclitaxel and metformin f...

Descripción completa

Detalles Bibliográficos
Autores principales: Braghiroli, Maria Ignez, de Celis Ferrari, Anezka C R, Pfiffer, Tulio Eduardo, Alex, Alexandra Kichfy, Nebuloni, Daniela, Carneiro, Allyne S, Caparelli, Fernanda, Senna, Luiz, Lobo, Juliana, Hoff, Paulo Marcelo, Riechelmann, Rachel P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544571/
https://www.ncbi.nlm.nih.gov/pubmed/26316884
http://dx.doi.org/10.3332/ecancer.2015.563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544571/
https://www.ncbi.nlm.nih.gov/pubmed/26316884
http://dx.doi.org/10.3332/ecancer.2015.563

Ejemplares similares